(19)
(11)EP 2 249 888 B8

(12)CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15)Correction information:
Corrected version no 1 (W1 B1)

(48)Corrigendum issued on:
06.09.2017 Bulletin 2017/36

(45)Mention of the grant of the patent:
02.08.2017 Bulletin 2017/31

(21)Application number: 09709491.6

(22)Date of filing:  02.02.2009
(51)International Patent Classification (IPC): 
A61L 27/46(2006.01)
A61L 27/56(2006.01)
(86)International application number:
PCT/US2009/032827
(87)International publication number:
WO 2009/102567 (20.08.2009 Gazette  2009/34)

(54)

BONE IMPLANT COMPOSITE

KNOCHENIMPLANTAT-KOMPOSIT

COMPOSITE D'IMPLANT OSSEUX


(84)Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

(30)Priority: 11.02.2008 US 29095

(43)Date of publication of application:
17.11.2010 Bulletin 2010/46

(73)Proprietor: Collagen Matrix, Inc.
Oakland, NJ 07436 (US)

(72)Inventors:
  • LI, Shu-tung
    Oakland, New Jersey 07436 (US)
  • YUEN, Debbie
    Woodcliff Lake, New Jersey 07675 (US)
  • CHEN, Hui-Chen
    Wayne, NJ 07470 (US)

(74)Representative: Michalski Hüttermann & Partner Patentanwälte mbB 
Speditionstraße 21
40221 Düsseldorf
40221 Düsseldorf (DE)


(56)References cited: : 
EP-A1- 1 825 868
WO-A2-2008/002682
US-A- 4 888 366
US-B1- 6 187 047
US-B2- 7 153 938
WO-A2-2006/095154
US-A- 4 795 467
US-A1- 2005 288 795
US-B1- 6 201 039
US-B2- 7 163 965
  
  • YUNOKI S ET AL: "Control of pore structure and mechanical property in hydroxyapatite/collagen composite using unidirectional ice growth", MATERIALS LETTERS, NORTH HOLLAND PUBLISHING COMPANY. AMSTERDAM, NL, vol. 60, no. 8, 1 April 2006 (2006-04-01), pages 999-1002, XP027897872, ISSN: 0167-577X [retrieved on 2006-04-01]
  
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).